ID   MHH-TALL-2
AC   CVCL_9825
SY   MHH-TALL2
DR   Cosmic; 1281376
DR   Cosmic; 2602922
DR   DSMZ; ACC-728
DR   DSMZCellDive; ACC-728
DR   Wikidata; Q54905550
RX   PubMed=9697876;
CC   Doubling time: ~60-72 hours (DSMZ=ACC-728).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-728
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 10,12
ST   D19S433: 13,16
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 21,26
ST   Penta D: 9,11
ST   Penta E: 14,17
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=9697876; DOI=10.1038/sj.leu.2401102;
RA   Tomeczkowski J., Frick D., Schwinzer B., Wittner N., Ludwig W.-D.,
RA   Reiter A., Welte K., Sykora K.-W.;
RT   "Expression and regulation of c-kit receptor and response to stem cell
RT   factor in childhood malignant T-lymphoblastic cells.";
RL   Leukemia 12:1221-1229(1998).
//